In primary brain tumor samples, Bmi1 expression was marked in 16/19 (84%) of GBM, 5/7 (71%) of oligodendroglioma and 3/7 (42%) of astrocytoma. The gene discussed is BMI1; the disease is astrocytoma (excluding glioblastoma).